Coherent Market Insights added Latest Research Report titled " Urolithiasis Management Devices Market, by Device Type (Shock Wave Lithotripters and Ureteroscopes), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 " to its Large Report database.

Urolithiasis is referred to as kidney stone and is a condition that is characterized by presence of a calculi or a solid piece material in the urinary tract of an individual. These solid mass commonly known as kidney stone is typically formed in the renal area that is eliminated from the body through the urine stream. The stones that are smaller in size may pass off the body without any symptoms, however, lumps larger than 5 millimeters in size can lead to blockage of the ureter that may cause severe pain in the abdominal area and lower back. This may result in symptoms that includes pain during urination, vomiting or blood in the urine. Urolithiasis is caused due to combination of environmental and genetic factors. It can also be caused due various factors such as obesity, hyperparathyroidism, and high urine calcium levels.

Market Dynamics

Rising incidence of chronic kidney diseases is one of the major factors responsible for growth of global urolithiasis management devices market. According to the National Kidney Foundation 2016, around 10% of the global population is affected by chronic kidney diseases, and over 2 million people worldwide are receiving treatment for this disease. According to the World Health Organization 2014, one in every 20 people develop kidney stone at some point in their lives. Moreover, growth of the urolithiasis management devices market can also be attributed to rising adoption of percutaneous nephrolithotomy (PCNL). PCNL refers to the procedures or treatments performed on patients suffering with large or irregularly shaped kidney stones for which normal breaking through shock wave lithotripsy is not enough. According to the American Urological Association 2016, PCNL was reported to be the most fast growing renal disease management technique in the recent past whereas, the European Association of Urology guidelines in 2014 recommended PCNL treatment for renal stones that are larger than 2 cm in their diameter. The National Kidney Foundation 2015, also stated that around half a million patients are admitted in emergency rooms for treatment of kidney stone each year. 

Competitive Insights

Key players operating in the global urolithiasis management devices market include C.R. Bard, Cook Medical, Boston Scientific Corporation, Karl Storz, Allengers Medical Systems, Inc., Olympus Corporation, Electro Medical Systems SA, Dornier MedTech GmbH, Direx Group, and others. Market players are focused towards developing technologically advanced products to sustain their presence in the market. For instance, in January 2016, Boston Scientific Corporation introduced the LithoVue single use digital flexible ureteroscope for minimally invasive endoscopic procedures to diagnose kidney stones in the bladder, kidney, and ureter.

Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/1684

Regional Insights

On the basis of region, the global urolithiasis management devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global urolithiasis management devices market and is expected to retain its dominance over the forecast period, owing to presence of a large patient pool suffering from urolithiasis. According to the University of Wisconsin Foundation 2013, the incidence of urolithiasis is estimated to be 13% in men and 7% in females in the U.S.

Moreover, high presence of leading market players developing innovative and technologically advanced products for the treatment of the kidney disorders in the region is also expected to fuel growth of the regional market. For instance, in 2017 Dornier MedTech, an Atlanta-based medical device company, introduced DORNIER DELTA III, an advanced kidney stone treatment lithotripter that facilitates enhanced efficiency, maximized energy and powerful imaging with its patent protected 'Unified Hand Control' for ease of use and time-saving workflow.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]